| Previous Section | Index | Home Page |
4 Jun 2007 : Column 287W—continued
Depression: Diamorphine
Mr. Lansley: To ask the Secretary of State for Health what the net ingredient cost of (a) anti-depressants and (b) diamorphine dispensed in the community was in each year since 1997. [137319]
Caroline Flint: The net ingredient cost (NIC) for anti-depressants and diamorphine hydrochloride dispensed in the community, in England, from 1997 to 2006, is in the following table:
| NIC ( £000 ) | ||
| Diamorphine hydrochloride | Anti-depressants | |
For diamorphine, the British National Formulary (BNF) chemical name of ‘diamorphine hydrochloride’ is used. For anti-depressants, the figures cover all dispensing in the BNF section 4.3.
The use of diamorphine hydrochloride in 2005 was affected by supply problems. Costs of anti-depressants and diamorphine hydrochloride in 2005 and 2006 were affected by the new PPRS agreement (February 2005) and new arrangements for generic prices introduced in April 2005.
Doctors: Contracts
Mr. Hoban: To ask the Secretary of State for Health on what date her Department gained Treasury approval for (a) the new GP contract introduced in 2004 and (b) the new consultant contract introduced in 2003. [137068]
Ms Rosie Winterton: New contracts for doctors formed part of the discussions between the Department and HM Treasury on the SR02 spending review, which concluded in July 2002.
Doctors: Training
Dr. Murrison: To ask the Secretary of State for Health how many non-EEA doctors have obtained training posts in the first round of application through the Medical Training Application Service. [128714]
Ms Rosie Winterton: As the process is ongoing, it is not yet possible to provide a breakdown of numbers as requested.
Ms Abbott: To ask the Secretary of State for Health what steps she is taking to encourage junior doctors who do not get a run-through training post to remain in the UK. [137210]
Ms Rosie Winterton: The Review Group is exploring the possibilities for creating further training opportunities where these can support local workforce requirements. For junior doctors who do not get a run-through training post there are a number of options, including, as in the past, non-training service posts, fixed term specialist training appointments and any other training posts that will continue to become available over the year. The Review Group is also exploring ways to support any doctors who do not secure training and to maximize the employment opportunities for them in the United Kingdom.
Ms Abbott: To ask the Secretary of State for Health whether the Medical Training Application Service system will be audited and reviewed before doctors are allocated their jobs; and if she will make a statement. [137211]
Ms Rosie Winterton: A full security review of the system has now been completed by information technology security testing specialists, MWR Infosecurity. Action has been taken to further strengthen the security arrangements and MWR now consider the Medical Training Application System site to be robust and above average for security. Both MWR and CESG (Communications Electronic Security Group), the national technical authority for information assurance, have confirmed that appropriate and sufficiently comprehensive action has been taken. The site was therefore re-opened on 4 May, restricted to postgraduate deaneries only, to support the next steps in the recruitment process. Given the continuing concerns about MTAS, the computer system will now not be used for matching candidates to training posts, but will continue to be used for national monitoring.
Drugs: Greater London
Sarah Teather: To ask the Secretary of State for Health how many people were referred to NHS services as a result of drug addiction in each London health trust area in each of the last 10 years. [138496]
Caroline Flint: The information is not held in the format requested. However, the following table shows the number of referrals made by drug action teams in London from 2004.
| Number of referrals | |||
| Drug action team (DAT) | 2004-05 | 2005-06 | 2006-07 |
Sarah Teather: To ask the Secretary of State for Health what estimate she has made of the total cost of treating (a) drug, (b) alcohol and (c) smoking related illnesses in each London primary care trust in each of the last five years. [138498]
Caroline Flint: The information requested is not held centrally. However, the following table shows the cost of drug related illnesses broken down by Drug Action Teams in London, with allocations for 2007-08 to be finalised in June.
Nationally, the national health service spends between £1.4 billion and £1.7 billion on alcohol related illnesses, and £1.4 billion and £1.7 billion on smoking related illnesses.
| PTB for | |||||
| Drug action team | 2002-03 | 2003-04 | 2004-05 | 2005-06 | 2006-07 |
| Next Section | Index | Home Page |